AtaiBeckley (ATAI) Other Accumulated Expenses (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Other Accumulated Expenses of $2.5 million in Q1 2026, down 2.61% quarter-over-quarter from $2.6 million in Q4 2025.

AtaiBeckley (ATAI) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

AtaiBeckley's Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $2.5 million for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (changed N/A YoY), while the FY2025 annual figure was $2.6 million, up 386.03% from the prior year.
  • Other Accumulated Expenses was $2.5 million for Q1 2026 at AtaiBeckley, down from $2.6 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.6 million in Q4 2024 to a low of $8000.0 in Q3 2021.
  • The 5-year median for Other Accumulated Expenses is $680000.0 (2024), against an average of $758764.7.
  • Biggest YoY gain for Other Accumulated Expenses was 386.03% in 2025; the steepest drop was 386.03% in 2025.
  • A 3-year view of Other Accumulated Expenses shows it stood at $537000.0 in 2024, then jumped by 386.03% to $2.6 million in 2025, then dropped by 2.61% to $2.5 million in 2026.
  • The last three Other Accumulated Expenses figures came in at $2.5 million (Q1 2026), $2.6 million (Q4 2025), and $537000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 AtaiBeckley 1.45 Bn 1.45 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.54 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 178,000.00
Jun 30, 2025 421,000.00
Mar 31, 2025 2.34 Mn
Dec 31, 2024 537,000.00
Dec 31, 2024 2.65 Mn
Sep 30, 2024 147,000.00
Jun 30, 2024 680,000.00
Mar 31, 2024 877,000.00
Dec 31, 2023 1.10 Mn
Sep 30, 2023 463,000.00
Jun 30, 2023 890,000.00
Mar 31, 2023 795,000.00
Dec 31, 2022 706,000.00
Sep 30, 2022 260,000.00
Jun 30, 2022 1.11 Mn
Mar 31, 2022 227,000.00
Dec 31, 2021 51,000.00
Sep 30, 2021 8,000.00